Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.

MLA

Bonezzi, Katiuscia, et al. “Inhibition of SIRT2 Potentiates the Anti-Motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies.” Neoplasia (New York, N.Y.), vol. 14, no. 9, Sept. 2012, pp. 846–54. EBSCOhost, https://doi.org/10.1593/neo.12728.

APA

Bonezzi, K., Belotti, D., North, B. J., Ghilardi, C., Borsotti, P., Resovi, A., Ubezio, P., Riva, A., Giavazzi, R., Verdin, E., & Taraboletti, G. (2012). Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies. Neoplasia (New York, N.Y.), 14(9), 846–854. https://doi.org/10.1593/neo.12728

Chicago

Bonezzi, Katiuscia, Dorina Belotti, Brian J North, Carmen Ghilardi, Patrizia Borsotti, Andrea Resovi, Paolo Ubezio, et al. 2012. “Inhibition of SIRT2 Potentiates the Anti-Motility Activity of Taxanes: Implications for Antineoplastic Combination Therapies.” Neoplasia (New York, N.Y.) 14 (9): 846–54. doi:10.1593/neo.12728.